In the news: data in the UK Data Service collection across the web

The NHS watchdog breached the Gambling Commission’s statistics guidance when it cited the regulator’s new harms survey, argued Regulus Partners partner Dan Waugh.

How are NHS negligence payouts calculated.

Health officials say they are prioritising people with the highest needs for ‘King Kong of weight-loss drugs’

Shipley MP Anna Dixon discusses the NHS in her latest column for the Telegraph & Argus.

Healthcare property giant Assura has called for investment in the sector and said that the UK is a turning point in its delivery of healthcare alongside its half-year results.

NHS England has proposed a phased rollout of tirzepatide, a promising weight-loss drug, to benefit patients most likely to achieve significant clinical outcomes.

The availability of weight loss drugs on the NHS doesn’t mean people can give up healthy lifestyles, Health Secretary Wes Streeting has warned.

The results of the second part of the annual NHS health survey for England 2022 released today, highlights the growing prevalence of chronic conditions and the dangers of missed diagnosis and early treatment.

The results of the second part of the annual NHS health survey for England 2022 released today, highlights the growing prevalence of chronic conditions and the dangers of missed diagnosis and early treatment. 

NICE publishes its guidance in full more than 12 months after initial draft release, with the institute working closely alongside the DCMS, DHSC and NHS England on implementation

Pleased that London is in the vanguard of providing an actual solution to the problem of obesity? As a nation the UK – self included – is getting fatter and fatter and thus less and less healthy, with the rise in type two diabetes an index of the problem. One of the most popular weight loss injections costs the NHS £122 per month per user.

The ‘King Kong of weight loss drugs’ will be available on the NHS but only patients with most need will get it

Mounjaro will be made available on the NHS but the rollout will be phased - only those with the highest need will get the jabs first meaning millions face a long wait

LABOUR are urging the SNP to mimic their plans to tackle obesity with weight-loss jabs.

Nearly 250,000 people in England could access the weight loss injection tirzepatide on the NHS under proposed plans.

More than 1.6 million Britons are set to get the ‘King Kong’ of fat jabs on the NHS over the next 12 years.

Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins. 

The National Institute for Health and Care Excellence is consulting on a phased roll-out of Eli Lilly’s weight loss drug tirzepatide – more commonly known as Mounjaro – as NHS England looks to combat obesity.

NHS chiefs are calling for a society-wide effort to tackle obesity as new figures reveal that almost a third of adults were living with obesity in 2022.

Around one in eight children between the ages of two and 10 in England are obese, according to an NHS survey.